Abstract
SAR and PK studies led to the identification of N-(1-{(3R)-3-(3,5-difluorophenyl)-3-[4-methanesulfonylphenyl] propyl}piperidin-4-yl)-N-ethyl-2-[4-methanesulfonylphenyl]acetamide as a highly potent and selective ligand for the human CCR5 chemokine receptor with good oral pharmacokinetic properties.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetanilides / chemical synthesis
-
Acetanilides / chemistry*
-
Acetanilides / pharmacokinetics*
-
Animals
-
CCR5 Receptor Antagonists*
-
Crystallography, X-Ray
-
Dogs
-
Humans
-
Models, Molecular
-
Molecular Structure
-
Piperidines / chemical synthesis
-
Piperidines / chemistry*
-
Piperidines / pharmacology*
-
Rats
-
Stereoisomerism
-
Structure-Activity Relationship
-
Sulfones / chemical synthesis
-
Sulfones / chemistry*
-
Sulfones / pharmacology*
-
Time Factors
Substances
-
Acetanilides
-
CCR5 Receptor Antagonists
-
Piperidines
-
Sulfones